Showing results (391-400 of 411) with videos related to
Sort By:
Pageof 42
Journal of General Internal Medicine|August 14, 2021
Engagement in Prescription Opioid Tapering Research: the EMPOWER Study and a Coproduction Model of SuccessAram Mardian, Luzmercy Perez, Ting Pun, et al.The Journal of Pain|December 28, 2022
Expectations for Improvement: A Neglected but Potentially Important Covariate or Moderator for Chronic Pain Clinical TrialsDale J Langford, Raissa Lou, Soun Sheen, et al.Nature Reviews. Disease Primers|November 6, 2020
Paediatric functional abdominal pain disordersNikhil Thapar, Marc A Benninga, Michael D Crowell, et al.Nature Reviews. Disease Primers|November 4, 2017
Functional dyspepsiaPaul Enck, Fernando Azpiroz, Guy Boeckxstaens, et al.JAMA Network Open|April 12, 2023
Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical TrialAnnabelle M Belcher, Thomas O Cole, Ebonie Massey, et al.The Journal of Headache and Pain|September 26, 2020
European Headache Federation recommendations for placebo and nocebo terminologyDimos D Mitsikostas, Charlotte Blease, Elisa Carlino, et al.Pain Medicine (Malden, Mass.)|December 27, 2019
Comparative Effectiveness of Cognitive Behavioral Therapy for Chronic Pain and Chronic Pain Self-Management within the Context of Voluntary Patient-Centered Prescription Opioid Tapering: The EMPOWER Study ProtocolBeth D Darnall, Sean C Mackey, Kate Lorig, et al.Plos One|May 17, 2019
Whole blood transcriptomic profiles can differentiate vulnerability to chronic low back painSusan G Dorsey, Cynthia L Renn, Mari Griffioen, et al.Pain Reports|July 8, 2026
Development of a core outcome set for clinical trials of extended reality for painGiulia Mesaroli, Courtney W Hess, Fahad Alam, et al.BMJ Open|June 24, 2019
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatmentAnnabelle M Belcher, Thomas O Cole, Aaron D Greenblatt, et al.Pageof 42